Quality assessment of oral antimalarial and antiretroviral medicines used by public health systems in Sahel countries
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0303289 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Amor R Cáceres-Pérez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Farmacia, Universidad de La Laguna, San Cristóbal de La Laguna, Spain. Hauptthemen laut MEDLINE: Antimalarials, Quality Control. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Interreg.
Abstract (Originalsprache)
Malaria and Human Immunodeficiency Virus infections are among the top 10 causes of death in low income countries. Furthermore, many medicines used in these treatment areas are substandard, which contributes to the high death rate. Using a monitoring system to identify substandard and falsified medicines, the study aims to evaluate the quality of antimalarial and antiretroviral medicines in Sahel countries, assessing site conditions, compliance of medicines with pharmacopoeia tests, formulation equivalence with a reference medicine, and the influence of climate on quality attributes. Ultra Performance Liquid Chromatography methods for eight active pharmaceutical ingredients were validated following the International Conference for Harmonization guideline for its detection and quantification. Quality control consists of visual inspections to detect any misinformation or imperfections and pharmacopeial testing to determine the quality of pharmaceutical products. Medicines which complied with uniformity dosage units and dissolution tests were stored under accelerated conditions for 6 months. Artemether/Lumefantrine and Lopinavir/Ritonavir formulations failed uniformity dosage units and disintegration tests respectively, detecting a total of 28.6% substandard medicines. After 6 months stored under accelerated conditions (40 °C // 75% relative humidity) simulating climatic conditions in Sahel countries, some medicines failed pharmacopeia tests. It demonstrated the influence of these two factors in their quality attributes. This study emphasizes the need of certified quality control laboratories as well as the need for regulatory systems to maintain standards in pharmaceutical manufacturing and distribution in these countries, especially when medicines are transported to rural areas where these climatic conditions are harsher.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Facultad de Farmacia, Universidad de La Laguna, San Cristóbal de La Laguna, Spain.
- Programa de Doctorado Ciencias Médicas y Farmacéuticas, Desarrollo y Calidad de Vida, Universidad de La Laguna, San Cristóbal de La Laguna, Spain.
- Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, San Cristóbal de La Laguna, Spain.
ORCID-Profile: Amor R Cáceres-Pérez, Javier Suárez-González, Ana Santoveña-Estévez
Förderung
- Interreg
Zitieren
APA
Cáceres-Pérez, A. R., Suárez-González, J., Santoveña-Estévez, A., & Fariña, J. B. (2024). Quality assessment of oral antimalarial and antiretroviral medicines used by public health systems in Sahel countries. PLOS ONE. https://doi.org/10.1371/journal.pone.0303289
Vancouver
Cáceres-Pérez AR, Suárez-González J, Santoveña-Estévez A, Fariña JB. Quality assessment of oral antimalarial and antiretroviral medicines used by public health systems in Sahel countries. PLOS ONE. 2024. doi:10.1371/journal.pone.0303289
BibTeX
@article{CceresPrez2024,
author = {Cáceres-Pérez, Amor R and Suárez-González, Javier and Santoveña-Estévez, Ana and Fariña, José B},
title = {Quality assessment of oral antimalarial and antiretroviral medicines used by public health systems in Sahel countries},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0303289}
}
EUVIMED